Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2002-03-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1006/BBRC.2002.6666PMID 11906173
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Systematic analysis of the TGF-beta-Smad signaling pathway in gastrointestinal cancer cells.

  2001cited by this paper
• Deregulated expression of cyclin D1 overrides antimitogenic signals

  2000cited by this paper
• Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis.

  2000cited by this paper
• Transcriptional control by the TGF‐β/Smad signaling system

  2000cited by this paper
• Antisense inhibition of cyclin D1 in human head and neck squamous cell carcinoma.

  2000cited by this paper
• Antisense cyclin D1 induces apoptosis and tumor shrinkage in human squamous carcinomas.

  1999cited by this paper
• Gene mutation of transforming growth factor β1 type II receptor in hepatocellular carcinoma

  1999cited by this paper
• Mutation analysis of transforming growth factor beta type II receptor, Smad2, and Smad4 in hepatocellular carcinoma.

  1999cited by this paper
• Transcriptional repression of the transforming growth factor-β type I receptor gene by DNA methylation results in the development of TGF-β resistance in human gastric cancer

  1999cited by this paper
• Up‐regulation of human telomerase catalytic subunit during gastric carcinogenesis

  1999cited by this paper
• Dysregulated expression of cyclin D1 in normal human mammary epithelial cells inhibits all-trans-retinoic acid-mediated G0/G1-phase arrest and differentiation in vitro.

  1999cited by this paper
• Establishment and characterization of four human hepatocellular carcinoma cell lines containing hepatitis B virus DNA.

  1999cited by this paper
• TGF-beta-1 up-regulates cyclin D1 expression in COLO-357 cells, whereas suppression of cyclin D1 levels is associated with down-regulation of the type I TGF-beta receptor.

  1999cited by this paper
• TGF‐β‐1 up‐regulates cyclin D1 expression in colo‐357 cells, whereas suppression of cyclin d1 levels is associated with down‐regulation of the type I TGF‐β receptor

  1999cited by this paper
• Mechanism of cyclin D1 (CCND1, PRAD1) overexpression in human cancer cells: Analysis of allele‐specific expression

  1998cited by this paper
• A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

  1998cited by this paper
• Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification

  1998cited by this paper
• TGF-β1 effects on proliferation of rat intestinal epithelial cells are due to inhibition of cyclin D1 expression

  1998cited by this paper
• Genetic integrity of transforming growth factor β (TGF‐β) receptors in cervical carcinoma cell lines: loss of growth sensitivity but conserved transcriptional response to TGF‐β

  1998cited by this paper
• Disruption of the antiproliferative TGF-β signaling pathways in human pancreatic cancer cells

  1998cited by this paper
• Genetic integrity of transforming growth factor beta (TGF-beta) receptors in cervical carcinoma cell lines: loss of growth sensitivity but conserved transcriptional response to TGF-beta.

  1998cited by this paper
• Expression of transforming growth factor beta type II receptor reduces tumorigenicity in human gastric cancer cells.

  1997cited by this paper
• Expression of Transforming Growth Factor β Type II Receptor Reduces Tumorigenicity in Human Gastric Cancer Cells

  1997cited by this paper
• Cyclin D1 antisense RNA destabilizes pRb and retards lung cancer cell growth.

  1997cited by this paper
• Cyclin D1 antisense RNA destabilizes pRb and retards lung cancer cell growth.

  1997cited by this paper
• Transforming growth factor beta stabilizes p15INK4B protein, increases p15INK4B-cdk4 complexes, and inhibits cyclin D1-cdk4 association in human mammary epithelial cells

  1997cited by this paper
• Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells.

  1997cited by this paper
• Sensitivity to transforming growth factor beta 1-induced growth arrest is common in human squamous cell carcinoma cell lines: c-MYC down-regulation and p21waf1 induction are important early events.

  1996cited by this paper
• TGF-beta mediated G1 arrest in a human melanoma cell line lacking p15INK4B: evidence for cooperation between p21Cip1/WAF1 and p27Kip1.

  1996cited by this paper
• Characterization of cell lines established from human hepatocellular carcinoma

  1995cited by this paper
• Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells.

  1995cited by this paper
• Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 1 receptors in normal, cirrhotic, and neoplastic human livers.

  1995cited by this paper
• Transforming growth factor—beta 1 (TGF‐β1) and TGF‐β1 receptors in normal, cirrhotic, and neoplastic human livers

  1995cited by this paper
• A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability.

  1995cited by this paper
• pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest

  1994cited by this paper
• Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age.

  1994cited by this paper
• p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest.

  1994cited by this paper
• Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma.

  1994cited by this paper
• Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression.

  1993cited by this paper
• Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma.

  1993cited by this paper

• Dissecting the role of the NADPH oxidase NOX4 in TGF-beta signaling in hepatocellular carcinoma

  2023cites this paper
• Identification of Growth Factors, Cytokines and Mediators Regulated by Artemisia annua L. Polyphenols (pKAL) in HCT116 Colorectal Cancer Cells: TGF-β1 and NGF-β Attenuate pKAL-Induced Anticancer Effects via NF-κB p65 Upregulation

  2022cites this paper
• Systematic Analysis of Cytostatic TGF-Beta Response in Mesenchymal-Like Hepatocellular Carcinoma Cell Lines

  2021cites this paper
• TGF-β plays a vital role in triple-negative breast cancer (TNBC) drug-resistance through regulating stemness, EMT and apoptosis.

  2018cites this paper
• MicroRNA-590-5p regulates proliferation and invasion in human hepatocellular carcinoma cells by targeting TGF-β RII

  2012cites this paper
• TGF-beta antiproliferative effects in tumor suppression Stephan

  2012cites this paper
• TGF-beta antiproliferative effects in tumor suppression.

  2012cites this paper
• Relationship between GST Yp Induction and Hepatocyte Proliferation in Rats Treated with Phase II Drug Metabolizing Enzyme Inducers

  2008cites this paper
• Tumor Suppressor and Pro-progression Roles for TGF-β in Breast Cancer

  2008cites this paper
• Abnormal Expression of Hepatic Transforming Growth Factor-β1 at the Early Stage of Hepatocellular Carcinoma Formation

  2008cites this paper
• KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor.

  2008cites this paper
• Clinical Impact of Plasma TGF-β1 and Circulating TGF-β1 mRNA in Diagnosis of Hepatocellular Carcinoma

  2008cites this paper
• KSHV LANA inhibits TGF- (cid:1) signaling through epigenetic silencing of the TGF- (cid:1) type II receptor

  2008cites this paper
• Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma.

  2008cites this paper
• Modification of the tumor microenvironment to enhance immunity.

  2007cites this paper
• Myostatin Induces Cyclin D1 Degradation to Cause Cell Cycle Arrest through a Phosphatidylinositol 3-Kinase/AKT/GSK-3β Pathway and Is Antagonized by Insulin-like Growth Factor 1*

  2006cites this paper
• Cyclooxygenase-2 inhibits novel ginseng metabolite-mediated apoptosis.

  2005cites this paper
• Intrahepatic cholangiocarcinoma escapes from growth inhibitory effect of transforming growth factor-β1 by overexpression of cyclin D1

  2005cites this paper
• The endogenous ratio of Smad2 and Smad3 influences the cytostatic function of Smad3.

  2005influential citation
• Transforming growth factor-beta (TGF-beta) activates cytosolic phospholipase A2alpha (cPLA2alpha)-mediated prostaglandin E2 (PGE)2/EP1 and peroxisome proliferator-activated receptor-gamma (PPAR-gamma)/Smad signaling pathways in human liver cancer cells. A novel mechanism for subversion of TGF-beta-i

  2004cites this paper
• Potential roles of antisense therapy in the molecular targeting of genes involved in cancer (review).

  2004cites this paper
• Transforming Growth Factor-β (TGF-β) Activates Cytosolic Phospholipase A2α (cPLA2α)-mediated Prostaglandin E2 (PGE)2/EP1 and Peroxisome Proliferator-activated Receptor-γ (PPAR-γ)/Smad Signaling Pathways in Human Liver Cancer Cells

  2004cites this paper
• Involvement of c-Src kinase in the regulation of TGF-β1-induced apoptosis

  2004cites this paper
• AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity

  2004cites this paper
• Reduction of Menin Expression Enhances Cell Proliferation and Is Tumorigenic in Intestinal Epithelial Cells*

  2004cites this paper
• Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer

  2004cites this paper
• Transforming growth factor-β (TGF-β) activates cytosolic phospholipase A2α (cPLA2α)-mediated prostaglandin E2 (PGE)2/EP1 and peroxisome proliferator-activated-γ (PPAR-γ)/Smad signaling pathways in human liver cancer cells. A NOVEL MECHANISM FOR SUBVERSION OF TGF-β-INDUCED MITOINHIBITION.

  2004cites this paper
• Transforming growth factor‐β1‐induced apoptosis is blocked by β1‐integrin‐mediated mitogen‐activated protein kinase activation in human hepatoma cells

  2004cites this paper
• Correlation analysis of cyclin D1 aberrant expression and telomerase activity during hepatocellular canceration and its significance

  2003cites this paper
• A novel ginseng saponin metabolite induces apoptosis and down-regulates fibroblast growth factor receptor 3 in myeloma cells.

  2003cites this paper
• Transforming growth factor-beta1 stimulated protein kinase B serine-473 and focal adhesion kinase tyrosine phosphorylation dependent on cell adhesion in human hepatocellular carcinoma SMMC-7721 cells.

  2003cites this paper
• TGF-β1 -promoted epithelial-to-mesenchymal transformation and cell adhesion contribute to TGF-β1 -enhanced cell migration in SMMC-7721 cells

  2003cites this paper